- Home
- KEY vs CNC Comparison
KEY vs CNC Comparison
Compare KEY & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KEY | CNC |
|---|---|---|
| Founded | 1825 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.6B | 18.7B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | KEY | CNC |
|---|---|---|
| Price | $20.49 | $40.59 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 17 |
| Target Price | $20.25 | ★ $40.06 |
| AVG Volume (30 Days) | ★ 17.9M | 7.3M |
| Earning Date | 01-20-2026 | 02-03-2026 |
| Dividend Yield | ★ 3.97% | N/A |
| EPS Growth | ★ 34785.88 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | $5,934,000,000.00 | ★ $167,680,000,000.00 |
| Revenue This Year | $77.19 | $32.54 |
| Revenue Next Year | $6.55 | $0.19 |
| P/E Ratio | $23.89 | ★ N/A |
| Revenue Growth | ★ 22.30 | 14.57 |
| 52 Week Low | $12.73 | $25.08 |
| 52 Week High | $20.84 | $66.81 |
Technical Indicators
Market Signals| Indicator | KEY | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 75.76 | 63.87 |
| Support Level | $18.26 | $37.25 |
| Resistance Level | $19.73 | $41.74 |
| Average True Range (ATR) | 0.43 | 1.15 |
| MACD | 0.23 | 0.17 |
| Stochastic Oscillator | 87.37 | 75.72 |
Price Performance
Historical ComparisonAbout KEY KeyCorp
With assets of around $185 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.